Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

638-the-steady-progress-of-targeted-therapies-promising-advances-for-lung-cancer

Review: The steady progress of targeted therapies, promising advances for lung cancer

Lorenzo Bombardelli, Anton Berns

28 Apr 2016

https://doi.org/10.3332/ecancer.2016.638

Abstract | Full Article | PDF

632-characterisation-of-the-triple-negative-breast-cancer-phenotype-associated-with-the-development-of-central-nervous-system-metastases

Review: Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

Katerin Rojas Laimito, Angelo Gámez-Pozo, Juan Sepúlveda, Luis Manso, Rocío López-Vacas, Tomás Pascual, Juan A Fresno Vara, Eva Ciruelos

11 Apr 2016

https://doi.org/10.3332/ecancer.2016.632

Abstract | Full Article | PDF | Spanish

626-targeted-agents-in-epithelial-ovarian-cancer-review-on-emerging-therapies-and-future-developments

Review: Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments

Rajitha Lokadasan, Francis V James, Geetha Narayanan, Pranab K Prabhakaran

8 Mar 2016

https://doi.org/10.3332/ecancer.2016.626

Abstract | Full Article | PDF

582-effectiveness-and-safety-of-monoclonal-antibodies-for-metastatic-colorectal-cancer-treatment-systematic-review-and-meta-analysis

Review: Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis

Bruno Rosa, José Paulo de Jesus, Eduardo L de Mello, Daniel Cesar, Mauro M Correia

15 Oct 2015

https://doi.org/10.3332/ecancer.2015.582

Abstract | Full Article | PDF | Portuguese

564-highlights-from-the-2015-win-symposium-novel-targets-innovative-agents-and-advanced-technologies-a-winning-strategy

Conference Report: Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies—a WINning strategy?

Richard L Schilsky

13 Aug 2015

https://doi.org/10.3332/ecancer.2015.564

Abstract | Full Article | PDF

517-current-management-approach-to-hidradenocarcinoma-a-comprehensive-review-of-the-literature

Review: Current management approach to hidradenocarcinoma: a comprehensive review of the literature

Abhishek Soni, Nupur Bansal, Vivek Kaushal, Ashok Kr Chauhan

19 Mar 2015

https://doi.org/10.3332/ecancer.2015.517

Abstract | Full Article | PDF

514-report-on-the-56th-ash-annual-meeting-san-francisco-4-9-december-2014

Conference Report: Report on the 56th ASH Annual Meeting, San Francisco, 4–9 December 2014

Alberto Agazzi

26 Feb 2015

https://doi.org/10.3332/ecancer.2015.514

Abstract | Full Article | PDF

508-report-from-the-37th-san-antonio-breast-cancer-symposium-9-13th-december-2014-texas-usa

Conference Report: Report from the 37th San Antonio Breast Cancer Symposium, 9–13th December 2014, Texas, USA

M Ahmed, E Esposito

4 Feb 2015

https://doi.org/10.3332/ecancer.2015.508

Abstract | Full Article | PDF

499-targeted-therapy-with-propranolol-and-metronomic-chemotherapy-combination-sustained-complete-response-of-a-relapsing-metastatic-angiosarcoma

Case Report: Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma

Shripad Banavali, Eddy Pasquier, Nicolas André

8 Jan 2015

https://doi.org/10.3332/ecancer.2015.499

Abstract | Full Article | PDF

498-pace-continuous-innovation-indicators-a-novel-tool-to-measure-progress-in-cancer-treatments

Policy: PACE Continuous Innovation Indicators—a novel tool to measure progress in cancer treatments

Silvia Paddock, Lauren Brum, Kathleen Sorrow, Samuel Thomas, Susan Spence, Catharina Maulbecker-Armstrong, Clifford Goodman, Michael Peake, Gordon McVie, Gary Geipel, Rose Li

7 Jan 2015

https://doi.org/10.3332/ecancer.2015.498

Abstract | Full Article | PDF

More from ecancer